Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
560-05-009 ISMRM Abstract

Radiomics for Differentiating Benign Lesions from DCIS in Segmental NME: A Multicenter Retrospective Breast DCE-MRI Study

Primary: Body - Breast
Secondary: Analysis Methods - Radiomics
560-05-009 · Acquisition Strategies Across Organs and Field Strengths · Wednesday, 13 May, 4:00 PM–4:55 PM · Digital Posters Row A
Keywords: Radiomics Ductal carcinoma in situ Non-mass enhancement (NME)
Accepted
Jiajing Huang 1,2, Zhendong Luo2, Tao Ai3, Zhiqiang Liu3, Qiongyu Ye4, Jinjie Li2, Qiyang Jiang5, Weiwei Yao2, Jianxun Lv2, Xinping Shen2
1Shenzhen University, Shenzhen, China
2Department of Radiology, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China
3Department of Radiology, Tongji Hospital, Wuhan, China
4Department of Ultrasonography, Shenzhen Baoan Women's and Children's Hospital, Shenzhen, China
5The First School of Clinical Medicine,Southern Medical University, Guangzhou, Guangdong, China
Presenting Author: Jiajing Huang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Morris E, Comstock C, Lee C, LehmanC, Ikeda D, N. G., ACR BI-RADS®magnetic resonance imaging. In: ACR BIRADS® Atlas, Breast Imaging Reporting andData System., Reston, VA: American College of Radiology, (2013).
2. K. Christiane K, S. Simone, L. Claudia C, M.-S. Nuschin, W. Eva, F. Rolf, K. Walther, S. Hans H, Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer, J Clin Oncol, 23 (2005) 8469-8476. doi:10.1200/JCO.2004.00.4960 [doi]
3. Zhang J, Wang L, Liu HF. Imaging Features Derived From Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Differentiate Malignant From Benign Breast Lesions: A Systematic Review and Meta-Analysis. J Comput Assist Tomogr. 2022 May-Jun 01;46(3):383-391. doi: 10.1097/RCT.0000000000001289 [doi]
4. Lee SE, Lee JH, Han K, Kim EK, Kim MJ, Moon HJ, Yoon JH, Park VY. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management. Eur Radiol. 2020 May;30(5):2773-2781. doi: 10.1007/s00330-019-06620-y [doi]
5. Torous VF, Resteghini NA, Phillips J, et al. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging. Arch Pathol Lab Med. 2021;145(10):1264-1269. doi:10.5858/arpa.2020-0266-oa [doi]
6. Gruenberg J, Ravindran A, Visscher D, Valencia E, Wickre M. Histologic correlation of breast biopsies presenting as non-mass enhancing lesions on magnetic resonance imaging: a contemporary single institutional series. Am J Clin Pathol. 2020;154(Supplement_1):S155-S155. doi:10.1093/ajcp/aqaa161.338 [doi]
7. Woodhams R, Matsunaga K, Kan S, et al. ADC Mapping of Benign and Malignant Breast Tumors. Magn Reson Med Sci. 2005;4(1):35-42. doi:10.2463/mrms.4.35 [doi]
8. Peila R, Arthur R, Rohan TE. Risk factors for ductal carcinoma in situ of the breast in the UK Biobank cohort study. Cancer Epidemiol. 2020;64:101648. doi:10.1016/j.canep.2019.101648 [doi]
9. Qin X, Strand SH, Lee MR, et al. Single cell expression analysis of ductal carcinoma in situ identifies complex genotypic-phenotypic relationships altering epithelial composition. Published online October 12, 2023. doi:10.1101/2023.10.10.561724 [doi]
10. Rajan PB, Perry RH. A quantitative study of patterns of basement membrane in ductal carcinoma In situ (DCIS) of the breast. Breast J. 1995;1(5):315-321. doi:10.1111/j.1524-4741.1995.tb00255.x [doi]
11. Brisken C, O’Malley B. Hormone Action in the Mammary Gland. Cold Spring Harbor Perspect Biol. 2010;2(12):a003178-a003178. doi:10.1101/cshperspect.a003178 [doi]
12. Heller SL, Young Lin LL, Melsaether AN, Moy L, Gao Y. Hormonal effects on breast density, fibroglandular tissue, and background parenchymal enhancement. Radiographics. 2018;38(4):983-996. doi:10.1148/rg.2018180035 [doi]
13. Kuling G, Brooks JD, Curpen B, Warner E, Martel AL. Impact of menopause and age on breast density and background parenchymal enhancement in dynamic contrast-enhanced magnetic resonance imaging. J Med Imaging. 2025;12(S2). doi:10.1117/1.jmi.12.s2.s22002 [doi]
14. Yoshida A, Hayashi N, Akiyama F, et al. Ductal carcinoma In situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. Clin Breast Cancer. 2012;12(6):398-403. doi:10.1016/j.clbc.2012.08.002 [doi]
15. Muyzhnek EL, Kiselev VI, Jakobs OE, et al. Fibrosclerosis and sclerosing adenosis with microcalcifications in the breast. Molecular pathogenesis, timely diagnosis and treatment. Res Pract Med J. 2019;6(2):75-85. doi:10.17709/2409-2231-2019-6-2-8 [doi]
16. Souri Z, Kiani P. The role of apparent diffusion coefficient (ADC) in differentiating between benign and malignant breast lesions in a sample of iranian women: diffusion weighted in breast MRI. Arch Breast Cancer. 2025;12(1):105-113. doi:10.32768/abc.2025121105-113 [doi]
17. Polat AV, Ozbay A, Aydın R, Aslan K, Bayrak İK. Diagnostic value of apparent diffusion coefficients to differentiate benign and malignant breast lesions. J Exp Clin Med. 2014;30(4):305-310. doi:10.5835/jecm.omu.30.04.005 [doi]
18. Lopes C, Lopes-Conceição L, Fontes F, et al. Prevalence and persistence of anxiety and depression over five years since breast cancer diagnosis—the NEON-BC prospective study. Curr Oncol. 2022;29(3):2141-2153. doi:10.3390/curroncol29030173 [doi]
19. Blanks RG, Given-Wilson R, Alison R, Jenkins J, Wallis MG. An analysis of 11.3 million screening tests examining the association between needle biopsy rates and cancer detection rates in the english NHS breast cancer screening programme. Clin Radiol. 2019;74(5):384-389. doi:10.1016/j.crad.2019.01.015 [doi]
20. Daimiel Naranjo I, Gibbs P, Reiner JS, et al. Radiomics and machine learning with multiparametric breast MRI for improved diagnostic accuracy in breast cancer diagnosis. Diagnostics. 2021;11(6):919. doi:10.3390/diagnostics11060919 [doi]
21. Reig B, Ha R. Editorial on “diagnosis of benign and malignant breast lesions on DCE‐MRI by using radiomics and deep learning with consideration of peritumor tissue.” J Magn Reson Imaging. 2020;51(3):810-811. doi:10.1002/jmri.27025 [doi]
22. Greenwood HI, Wilmes LJ, Kelil T, Joe BN. Role of breast MRI in the evaluation and detection of DCIS: opportunities and challenges. J Magn Reson Imaging. 2020;52(3):697-709. doi:10.1002/jmri.26985 [doi]
23. Grimm LJ, Rahbar H, Abdelmalak M, Hall AH, Ryser MD. Ductal carcinoma in situ: state-of-the-art review. Radiology. 2022;302(2):246-255. doi:10.1148/radiol.211839 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/560-05-009